Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: Less prevalent and predictive than previously thought?

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 2, 2015, Pages 134-139

  Hebson, Camden ^a   New, Tamara ^b   Record, Elizabeth ^b   Oster, Matthew ^a   Ehrlich, Alexandra ^a   Border, William ^a   James Herry, Angelica ^b   Kanaan, Usama ^a  

^a SIBLEY HEART CENTER CARDIOLOGY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

echocardiogram; pediatrics; pulmonary hypertension; sickle cell disease; tricuspid regurgitant velocity

Indexed keywords

HYDROXYUREA;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CEREBROVASCULAR ACCIDENT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SICKLE CELL ANEMIA; TRICUSPID REGURGITANT VELOCITY; CASE CONTROL STUDY; COMPLICATION; HYPERTENSION, PULMONARY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; PULMONARY ARTERY; TRICUSPID VALVE REGURGITATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MALE; PROGNOSIS; PULMONARY ARTERY; RETROSPECTIVE STUDIES; TRICUSPID VALVE INSUFFICIENCY; YOUNG ADULT;

EID: 84924241100     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000184     Document Type: Article

References (23)

1. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886-895.
2. Ataga KI, Moore CG, Jones S, et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol. 2006;134:109-115.
3. Castro O, Gladwin MT. Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management. Hematol Oncol Clin North Am. 2005;19:881-896, vii.
4. Collins FS, Orringer EP. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. Am J Med. 1982;73:814-821.
5. Sutton LL, Castro O, Cross DJ, et al. Pulmonary hypertension in sickle cell disease. Am J Cardiol. 1994;74:626-628.
6. Kato GJ. TRV: a physiological biomarker in sickle cell disease. Pediatr Blood Cancer. 2012;58:831-832.
7. Parent F, Bachir D, Inamo J, et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med. 2011;365:44-53.
8. Ambrusko SJ, Gunawardena S, Sakara A, et al. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatr Blood Cancer. 2006;47:907-913.
9. Pashankar FD, Carbonella J, Bazzy-Asaad A, et al. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. Pediatrics. 2008;121: 777-782.
10. Onyekwere OC, Campbell A, Teshome M, et al. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol. 2008;29:309-312.
11. Dham N, Ensing G, Minniti C, et al. Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease. Am J Cardiol. 2009;104:713-720.
12. Lee MT, Small T, Khan MA, et al. Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years. Brit J Haematol. 2009;146:437-441.
13. Suell MN, Bezold LI, Okcu MF, et al. Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2005;27:654-658.
14. Qureshi N, Joyce JJ, Qi N, et al. Right ventricular abnormalities in sickle cell anemia: evidence of a progressive increase in pulmonary vascular resistance. J Pediatr. 2006; 149:23-27.
15. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137:376-387.
16. Berger RM, Beghetti M, Humpl T, et al. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet. 2012;379:537-546.
17. Paulin R, Michelakis ED. The estrogen puzzle in pulmonary arterial hypertension. Circulation. 2012;126:1016-1019.
18. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Int Med. 1987;107:216-223.
19. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023-1030.
20. Kjaergaard J, Snyder EM, Hassager C, et al. Impact of preload and afterload on global and regional right ventricular function and pressure: a quantitative echocardiography study. J Am Soc Echocardiogr. 2006;19:515-521.
21. Liem RI, Young LT, Thompson AA. Tricuspid regurgitant velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Haematologica. 2007;92:1549-1552.
22. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111-117.
23. Fraisse A, Jais X, Schleich JM, et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis. 2010; 103:66-74.